AIR-STEMI Trial Finds Physiology-Guided Revascularisation Lowers Cardiovascular Events in STEMI Patients
The AIR-STEMI trial, a multicentre randomized study involving 1,823 patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, found that physiology-guided complete revascularisation using functional coronary angiography reduced major cardiovascular events and improved procedural safety compared to conventional angiography. The trial assessed which non-culprit lesions required treatment based on fractional flow reserve values, guiding percutaneous coronary intervention decisions. Results were presented at ESC Congress 2026 and published in The New England Journal of Medicine.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (72/100). Lens Score 39/100.
Outlets measured: businessstandard, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (70–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 28 Oct, 10:57 am. Other outlets followed.